Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
10.50
+0.22 (2.14%)
Jul 2, 2026, 10:32 AM EDT - Market open

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6864595043,3823,19713,391
Market Cap Growth
31.08%-9.05%-85.09%5.78%-76.12%-
Enterprise Value
708.78453.23381.612,6602,29511,925
Last Close Price
10.508.319.8267.6067.60332.40
PS Ratio
4.442.702.2213.456.6942.67
PB Ratio
1.430.900.703.081.848.90
P/TBV Ratio
1.511.010.793.411.817.73
EV/Sales Ratio
4.682.661.6810.584.8038.00
Debt / Equity Ratio
0.930.820.610.200.240.01
Net Debt / Equity Ratio
0.08-0.01-0.17-0.66-0.52-1.01
Net Debt / EBITDA Ratio
-0.150.020.250.910.420.85
Net Debt / FCF Ratio
-0.220.030.322.152.964.92
Asset Turnover
0.110.140.150.120.210.23
Inventory Turnover
----121.4942.54
Quick Ratio
4.954.665.445.878.0812.51
Current Ratio
5.154.925.626.118.3812.79
Return on Equity (ROE)
-79.95%-51.08%-60.34%-63.02%-127.52%-180.29%
Return on Assets (ROA)
-27.56%-25.18%-36.76%-41.11%-95.15%-133.06%
Return on Invested Capital (ROIC)
-60.34%-57.36%-115.53%-143.02%-502.24%-2512.51%
Return on Capital Employed (ROCE)
-30.11%-27.49%-40.39%-44.70%-102.68%-144.08%
Buyback Yield / Dilution
-7.29%-6.87%-6.76%-15.75%-23.48%-6.72%
Total Shareholder Return
-7.29%-6.87%-6.76%-15.75%-23.48%-6.72%
SEC Filings: 10-K · 10-Q